Cerevance Media Center

Current News

October 8, 2024

Cerevance Achieves Second Milestone in Research Collaboration with Merck

Cerevance announced the achievement of the second milestone in its research collaboration with Merck, known as MSD outside of the United States and Canada. The research collaboration, which was announced in August of 2022, focuses on the identification and validation of novel therapeutic targets for Alzheimer’s disease. The achievement of this milestone triggers a payment from Merck to Cerevance.

READ FULL

August 12, 2024

Cerevance Appoints Sagar Vaidya, M.D., Ph.D., as Chief Medical Officer

Cerevance has appointed Dr. Sagar Vaidya, M.D., Ph.D., as Chief Medical Officer. Dr. Vaidya brings a wealth of experience in drug development, clinical research, and medical affairs, with a distinguished track record in advancing therapeutic programs for severe and life-threatening diseases.

READ FULL

May 2, 2024

Cerevance Achieves First Milestone in Research Collaboration with Merck

Cerevance achieves first milestone in research collaboration with Merck, known as MSD outside of the United States and Canada. The research collaboration, which was announced in August of 2022, focuses on the identification of novel therapeutic targets for Alzheimer’s disease. The achievement of this milestone triggers an undisclosed payment from Merck to Cerevance.

READ FULL

April 25, 2024

Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline

Cerevance announced an initial closing of its Series B-1 Extension financing round that will add $47 million to the $51 million previously raised bringing the total Series B-1 raise to $98 million.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

May 16, 2023

Phase 1 Data on CVN766 at American Society of Clinical Psychopharmacology (ASCP)

Date:
Tuesday, May 30, 2023
Time:
2:00pm – 4:00pm
Location:
Miami, Florida
Media:
Oral Presentation
Read full

May 9, 2023

Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development

Date:
Monday, May 15, 2023
Time:
Check schedule for times
Location:
British Columbia, Canada
Media:
Presentation
Read full

May 8, 2023

2023 RBC Capital Markets Global Healthcare Conference

Date:
Tuesday, May 16, 2023
Time:
9:00 – 9:25am ET
Location:
New York, NY
Media:
Presentation
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview